These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25861263)

  • 1. Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.
    Ma XR; Tang YL; Xuan M; Chang Z; Wang XY; Liang XH
    Gastroenterol Res Pract; 2015; 2015():908275. PubMed ID: 25861263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.
    Pan XN; Zheng LQ; Lai XH
    World J Gastroenterol; 2014 Oct; 20(38):14051-7. PubMed ID: 25320545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pooled analysis of mesenchymal stem cell-based therapy for liver disease.
    Zhao L; Chen S; Shi X; Cao H; Li L
    Stem Cell Res Ther; 2018 Mar; 9(1):72. PubMed ID: 29562935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials.
    Liu Y; Dong Y; Wu X; Xu X; Niu J
    Stem Cell Res Ther; 2022 May; 13(1):204. PubMed ID: 35578365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.
    Liang J; Zhang H; Zhao C; Wang D; Ma X; Zhao S; Wang S; Niu L; Sun L
    Int J Rheum Dis; 2017 Sep; 20(9):1219-1226. PubMed ID: 28217916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial.
    Suk KT; Yoon JH; Kim MY; Kim CW; Kim JK; Park H; Hwang SG; Kim DJ; Lee BS; Lee SH; Kim HS; Jang JY; Lee CH; Kim BS; Jang YO; Cho MY; Jung ES; Kim YM; Bae SH; Baik SK
    Hepatology; 2016 Dec; 64(6):2185-2197. PubMed ID: 27339398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous Bone Marrow Stem Cell Transplantation in Liver Cirrhosis after Correcting Nutritional Anomalies, A Controlled Clinical Study.
    Esmaeilzadeh A; Ommati H; Kooshyar MM; Jarahi L; Akhavan Rezayat K; Saberi S; Vosough M; Ghassemi A
    Cell J; 2019 Oct; 21(3):268-273. PubMed ID: 31210432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.
    Manzini BM; da Silva Santos Duarte A; Sankaramanivel S; Ramos AL; Latuf-Filho P; Escanhoela C; Kharmandayan P; Olalla Saad ST; Boin I; Malheiros Luzo ÂC
    Cytotherapy; 2015 Aug; 17(8):1052-65. PubMed ID: 26139545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
    Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Autologous Bone Marrow Stem Cell Therapy in Patients with Liver Cirrhosis: A Meta-analysis.
    Wu CX; Wang D; Cai Y; Luo AR; Sun H
    J Clin Transl Hepatol; 2019 Sep; 7(3):238-248. PubMed ID: 31608216
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl
    Zhang Y; Li R; Rong W; Han M; Cui C; Feng Z; Sun X; Jin S
    Cell Death Dis; 2018 Dec; 9(12):1186. PubMed ID: 30538216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in bile duct ligation rat model.
    Mohamed HE; Elswefy SE; Rashed LA; Younis NN; Shaheen MA; Ghanim AM
    Exp Biol Med (Maywood); 2016 Mar; 241(6):581-91. PubMed ID: 26811102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow-Derived Stem Cells for Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis.
    Ouyang S; Ouyang L; Li Y; Ye Y; Ban L
    Turk J Gastroenterol; 2021 Oct; 32(10):896-906. PubMed ID: 34787095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysis.
    Pankaj P; Zhang Q; Bai XL; Liang TB
    World J Gastroenterol; 2015 Jul; 21(28):8697-710. PubMed ID: 26229412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Immune-Mediated Liver Injury and Compromise Virus Control During Acute Hepatitis B Virus Infection in Mice.
    Qu M; Yuan X; Liu D; Ma Y; Zhu J; Cui J; Yu M; Li C; Guo D
    Stem Cells Dev; 2017 Jun; 26(11):818-827. PubMed ID: 28318408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.
    Amin MA; Sabry D; Rashed LA; Aref WM; el-Ghobary MA; Farhan MS; Fouad HA; Youssef YA
    Clin Transplant; 2013; 27(4):607-12. PubMed ID: 23923970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of cell- and colony stimulating factor-based therapy for liver cirrhosis: a network meta-analysis of randomized controlled trials.
    Sun X; Guo S
    Cytotherapy; 2022 May; 24(5):516-525. PubMed ID: 35227600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study.
    Jang YO; Kim YJ; Baik SK; Kim MY; Eom YW; Cho MY; Park HJ; Park SY; Kim BR; Kim JW; Soo Kim H; Kwon SO; Choi EH; Kim YM
    Liver Int; 2014 Jan; 34(1):33-41. PubMed ID: 23782511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis.
    Kim G; Eom YW; Baik SK; Shin Y; Lim YL; Kim MY; Kwon SO; Chang SJ
    J Korean Med Sci; 2015 Oct; 30(10):1405-15. PubMed ID: 26425036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.